Headquarters
USA

Cellino Biotech

Cellino’s purpose is to build a precision platform that personalizes human cells for all, focusing on Parkinson’s, diabetes and heart disease. Cellino’s platform combines label-free imaging and high-speed laser editing with machine learning to automate cell reprogramming, expansion and differentiation in a closed cassette format, enabling thousands of patient samples to be processed in parallel in a single facility.

Visit the Cellino Biotech website

About us

Engage with us

Quick links

Language editions

Privacy Policy & Terms of Service

Sitemap

© 2025 World Economic Forum